- Biologic biomarkers for tumor response and normal tissue toxicity in liver cancer SBRT
- Principal Investigator of a Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy followed by Sorafenib in Hepatocellular Carcinoma (details)
Laura Dawson
Laura Dawson
MD, FRCPC
Professor
Location
Princess Margaret Cancer Centre
610 University Avenue
Toronto, ON, M5G 2M9
Accepting
Please contact Faculty Member for more information
Degree/Qualification
MD, University of Toronto
FRCPC, Radiation Oncology
Appointments
Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Hospital/University Health Network
Associate Member, Institute of Medical Science Graduate Faculty, University of Toronto
Clinical Interests
Gastrointestinal malignancies, with a focus on hepatobiliary carcinoma and liver metastases, SBRT, IGRT, Normal tissue radiation toxicity
Research/Teaching
Research Synopsis
Publications and Awards
View PubMed search of this faculty member's recent publications.